June 27, 2024
The University of Cincinnati's John Winhusen and Caroline Freiermuth discussed the evidence-based practices implemented during the HEALing Communities Study to fight the opioid epidemic with Spectrum News.
June 1, 2020
Dr. Carl Fichtenbaum of the Division of Infectious Diseases at the UC College of Medicine was interviewed by CNBC on the safest ways to vacation this summer in the midst of COVID-19.
November 13, 2020
A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions. Yashu Dhamija, MD, a first-year fellow in the UC Division of Immunology, Allergy, and Rheumatology, presented his findings in an abstract while discussing a medically challenging case at the virtual American College of Allergy, Asthma and Immunology (ACAAI) scientific meeting held November 13-15.
February 15, 2022
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.
February 17, 2022
New UC research discovered a unique class of medications that act as blood thinners by inhibiting an enzyme in the genes of tick saliva. The research focused on novel direct thrombin inhibitors (DTI) from tick salivary transcriptomes, or messenger RNA molecules expressed by an organism. The result is the development of new anticoagulant medications that can be used to treat patients with a variety of coronary issues, including heart attacks. The study was published in Nature Communication.
February 24, 2022
Research from UC is examining a protein that plays a key role in heart failure. The study is funded by the National Heart, Lung, and Blood Institute for just over $2 million dollars for four years and is a second renewal of a previous grant given to Sakthivel Sadayappan, PhD, professor in the Division of Cardiovascular Health and Disease in the Department of Internal Medicine at the UC College of Medicine.
August 26, 2021
Researchers at the University of Cincinnati and UC Health have administered a first-of-its-kind potential COVID-19 therapy. The first dosing was administered to a patient at UC Medical Center in Cincinnati on Aug. 17.
September 28, 2021
The University of Cincinnati College of Medicine is opening what it calls a “heart bank” to collect tissue samples that can be used by researchers. Those samples will be stored in a biorepository to provide a potentially valuable resource to help researchers find answers to scientific questions.
January 25, 2022
Women who receive a kidney transplant have low rates of contraceptive use according to new research from the University of Cincinnati. The study, published in the Journal of Nephrology, finds an overall contraceptive use rate of 9.5% among women with kidney transplants in the United States.
March 31, 2022
Research from UC shows renewed hope in reducing hospitalizations from COVID-19 through the use of convalescent plasma when given early in the disease course. The study was published in the New England Journal of Medicine.